Large Molecule Page
Once biopharma companies optimize operations in order to free up hidden capacity, they have four options: build, acquire, partner or face the realities of outsourcing
North America and Europe will dominate the global biosimilars market as demand rises for these products
There are a number of points of view and opinions on how good or necessary biosimilars actually are
New therapeutics require an error-free, integrated approach to manufacture, shipment and storage
White Papers: In Depth Research
Posted: Aug 26, 2016
Parenteral drugs are taking a strong position alongside the more established oral solid dose forms and are quickly coming into their own.
Posted: Dec 20, 2015
Biopharma R&D spending by PhRMA members grew from $2 billion in 1980 to some $51.6 billion in 2013. While no one’s crystal ball can exactly predict where the industry is headed, it is clear that Biopharma is soaring.
Posted: Aug 05, 2015
When it comes to the biologics product development lifecycle, information management is an imperative that cannot be ignored.
Posted: Jan 06, 2015
The Best of Pharmaceutical Manufacturing eBook is a collection of the most-read feature articles from 2014, chosen by the Pharmaceutical Manufacturing digital audience.